Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. operates as a multinational pharmaceutical company. It engages in the manufacturing, developing and marketing a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics in the United States, Canada, Latin America, Eastern and Central Europe, Australia, South East Asia and South Africa. The company's strategy is to focus the business on core geographies and therapeutic classes, manage pipeline assets through strategic partnerships with other pharmaceutical companies and deploy cash with an appropriate mix of selective acquisitions, share buybacks and debt repurchases. It has operations in Australia, Barbados, Brazil, Canada, Czech Republic, Hungary, Mexico, Poland, Slovak Republic, Switzerland and the United States of America. Valeant Pharmaceuticals International was founded on March 29, 1994 and is headquartered in Montreal, Canada.